Katleen Verleysen has been active in the Life Sciences sector for over 20 years and held various CEO/management positions and board seats (Serenex (USA), ImmunExpress (USA), Oxford Biodynamics (UK), Pronota (Belgium), PharmaFluidics (Belgium), DNameIT (Belgium), Center for Medical Innovation (Belgium)). She successfully completed multiple rounds of funding for various companies. Prior to joining miDiagnostics, she was responsible for finetuning Imec’s healthcare strategy, as well as enabling strategic partnerships. She is a board member of Immunexpress, a Seattle based diagnostics company, representing the Janssen Family Office. Katleen holds a B.Sc. in Chemistry and a Ph.D. in Analytical Chemistry, from the University of Ghent. She was a postdoctoral fellow at the Medical Center of Duke University (NC, USA).